Revision history of "Our benefits all round support the use of SN1 methylating brokers in platinum-based mostly combination program against innovative NSCLC"

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 09:02, 26 August 2016Savefreon11 talk contribs 10,124 bytes +10,124 Our benefits all round support the use of SN1 methylating brokers in platinum-based mostly combination program against innovative NSCLC